Dr. Emily Stein
Dr. Emily Stein, Ph.D., is working to redefine the landscape of oral and systemic health. Her leadership is driving the development of cutting-edge microbiome modulatory products, while unraveling the intricacies of biofilm-related oral and systemic diseases.
Dr. Stein has 18 patents, has delivered over 23 professional lectures on the global stage and has earned numerous awards and accolades, making her a respected authority in the realm of oral microbiome and soft tissue inflammation.
Dr. Stein earned a Ph.D. in Microbiology at UC Berkeley and completed her Post-Doctoral Fellowship at Stanford University School of Medicine, in the Department of Immunology & Rheumatology.
The microbiome modulatory technology that she has developed holds promise in addressing an array of diseases that range from periodontal disease to cancer and diabetes.